1
|
Ichaoui H, Nasr SB, Gargouri F, Zribi A, Hermi A, Fendri S, Balti M, Ayari J, Khiari R, Msakni I, Mansouri N, Ghozzi S, Haddaoui A. Transformation of a prostatic adenocarcinoma into squamous cell carcinoma after luteinizing hormone-releasing hormone (LHRH) agonist and radiotherapy treatment. Pan Afr Med J 2019; 34:125. [PMID: 33708294 PMCID: PMC7906544 DOI: 10.11604/pamj.2019.34.125.19421] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2019] [Accepted: 06/29/2019] [Indexed: 11/11/2022] Open
Abstract
Squamous cell carcinoma of the prostate is rare and represents 0.5% to 1% of prostatic carcinomas. Transformation of prostatic adenocarcinoma into squamous cell carcinoma after LH-RH agonist intake has been reported in only 8 cases in the literature. To our knowledge, our case is the second pure squamous cell carcinoma observed after hormonotherapy and radiotherapy. We reported a case of a patient with prostatic adenocarcinoma treated by radical prostatectomy followed by radiotherapy. Eleven years later, he had a vesical recurrence of prostatic adenocarcinoma. Our patient had an endoscopic resection followed by injections of Triptorelin. Six months later, he developed a local recurrence of a squamous cell carcinoma.
Collapse
Affiliation(s)
- Hamza Ichaoui
- Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie.,The Military Hospital of Tunis, Department of Urology, Montfleury 1008, Tunis, Tunisia
| | - Sonia Ben Nasr
- Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie.,The Military Hospital of Tunis, Department of Medical Oncology, Montfleury 1008, Tunis, Tunisia
| | - Faten Gargouri
- Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie.,The Military Hospital of Tunis, Department of Pathology, Montfleury 1008, Tunis, Tunisia
| | - Aref Zribi
- Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie.,The Military Hospital of Tunis, Department of Medical Oncology, Montfleury 1008, Tunis, Tunisia
| | - Amine Hermi
- Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie.,The Military Hospital of Tunis, Department of Urology, Montfleury 1008, Tunis, Tunisia
| | - Sana Fendri
- Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie.,The Military Hospital of Tunis, Department of Medical Oncology, Montfleury 1008, Tunis, Tunisia
| | - Mehdi Balti
- Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie.,The Military Hospital of Tunis, Department of Medical Oncology, Montfleury 1008, Tunis, Tunisia
| | - Jihen Ayari
- Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie.,The Military Hospital of Tunis, Department of Medical Oncology, Montfleury 1008, Tunis, Tunisia
| | - Ramzi Khiari
- Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie.,The Military Hospital of Tunis, Department of Urology, Montfleury 1008, Tunis, Tunisia
| | - Issam Msakni
- Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie.,The Military Hospital of Tunis, Department of Pathology, Montfleury 1008, Tunis, Tunisia
| | - Nada Mansouri
- Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie.,The Military Hospital of Tunis, Department of Pathology, Montfleury 1008, Tunis, Tunisia
| | - Samir Ghozzi
- Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie.,The Military Hospital of Tunis, Department of Urology, Montfleury 1008, Tunis, Tunisia
| | - Abderrazek Haddaoui
- Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie.,The Military Hospital of Tunis, Department of Medical Oncology, Montfleury 1008, Tunis, Tunisia
| |
Collapse
|